Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.
Kandeil A, Mostafa A, Hegazy RR, El-Shesheny R, El Taweel A, Gomaa MR, Shehata M, Elbaset MA, Kayed AE, Mahmoud SH, Moatasim Y, Kutkat O, Yassen NN, Shabana ME, GabAllah M, Kamel MN, Abo Shama NM, El Sayes M, Ahmed AN, Elalfy ZS, Mohamed BM, Abd El-Fattah SN, El Hariri HM, Abdel Kader M, Azmy O, Kayali G, Ali MA.
Kandeil A, et al. Among authors: abd el fattah sn.
Vaccines (Basel). 2021 Mar 3;9(3):214. doi: 10.3390/vaccines9030214.
Vaccines (Basel). 2021.
PMID: 33802467
Free PMC article.